The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 330:1689 June 9, 1994 Number 23
NextNext

Pelvic Inflammatory Disease

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: The article by McCormack (Jan. 13 issue)1 makes no mention of the importance of routine screening for syphilis and the human immunodeficiency virus (HIV) in patients with pelvic inflammatory disease. Only two of the four treatment regimens adequately treat syphilis (those that include a full 14 days of doxycycline), and none of the regimens are ideal, since they do not include the drug of choice, penicillin2. In addition, patients with a diagnosis of syphilis need to have repeated Venereal Disease Research Laboratory (VDRL) tests at three and six months to check for a cure2; therefore, . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.